주식회사팍스젠바이오 / PaxGenBio Co., Ltd.
PaxGenBio Co., Ltd.'s KOBDi Score is 85.28 as of Sep 2026, down 4.53 points since Apr 2025; it rose in 3 and fell in 5 of the 12 monthly updates. As of Sep 2026 it is ahead of about 82% of companies in its industry, against 82% in Aug 2026 and 74% in Apr 2025. Its strongest position was 83% (Jul 2026) and its weakest 74% (Apr 2025).
A year earlier, in Aug 2025, its score was 88.28 and it was ahead of about 76% of companies in its industry.
| Sep 2026 | 85.28 | ahead of 82% |
| Aug 2026 | 85.24 | ahead of 82% |
| Jul 2026 | 85.40 | ahead of 83% |
| Jun 2026 | 85.40 | ahead of 83% |
| May 2026 | 87.36 | ahead of 83% |
| Apr 2026 | 88.22 | ahead of 83% |
| Mar 2026 | 88.22 | ahead of 83% |
| Feb 2026 | 88.16 | ahead of 83% |
| Dec 2025 | 88.16 | ahead of 82% |
| Aug 2025 | 88.28 | ahead of 76% |
| Jul 2025 | 89.97 | ahead of 77% |
| May 2025 | 89.97 | ahead of 75% |
| Apr 2025 | 89.81 | ahead of 74% |
Where is PaxGenBio Co., Ltd. located?
PaxGenBio Co., Ltd. is registered at Anyang-si, Gyeonggi-do, South Korea (postal code 16227).
What industry is PaxGenBio Co., Ltd. in?
PaxGenBio Co., Ltd. belongs to Manufacturing › Pharmaceuticals & Biologics › Manufacturing of medical supplies and other medicine-related products.
How many employees does PaxGenBio Co., Ltd. have?
PaxGenBio Co., Ltd. has 10–19 employees.
What is PaxGenBio Co., Ltd.'s KOBDi Score?
85.28 as of September 2026, ahead of about 82% of companies in its industry.
Who are PaxGenBio Co., Ltd.'s competitors?
Similar companies include 에스지엠, GDS and JINWOO VET PHARM.


